Announcement

Collapse
No announcement yet.

Vaccines (Basel) . Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Vaccines (Basel) . Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks


    Vaccines (Basel)


    . 2021 Apr 1;9(4):320.
    doi: 10.3390/vaccines9040320.
    Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks


    Jesse O'Shea 1 , Mark R Prausnitz 2 , Nadine Rouphael 1



    Affiliations

    Abstract

    Vaccines are an essential component of pandemic preparedness but can be limited due to challenges in production and logistical implementation. While vaccine candidates were rapidly developed against severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), immunization campaigns remain an obstacle to achieving herd immunity. Dissolvable microneedle patches are advantageous for many possible reasons: improved immunogenicity; dose-sparing effects; expected low manufacturing cost; elimination of sharps; reduction of vaccine wastage; no need for reconstitution; simplified supply chain, with reduction of cold chain supply through increased thermostability; ease of use, reducing the need for healthcare providers; and greater acceptability compared to traditional hypodermic injections. When applied to coronavirus disease 2019 (COVID-19) and future pandemic outbreaks, microneedle patches have great potential to improve vaccination globally and save many lives.

    Keywords: dissolvable microneedle patch; drug delivery; equity; skin vaccination; vaccine delivery.

Working...
X